nodes	percent_of_prediction	percent_of_DWPC	metapath
Selegiline—L-Phenylalanine—Melphalan—hematologic cancer	0.101	1	CrCrCtD
Selegiline—ABCB1—hematologic cancer	0.0689	1	CbGaD
Selegiline—CYP2A6—Methoxsalen—hematologic cancer	0.0201	0.0372	CbGbCtD
Selegiline—CYP1A2—Anagrelide—hematologic cancer	0.0171	0.0318	CbGbCtD
Selegiline—CYP2B6—Thiotepa—hematologic cancer	0.0168	0.0312	CbGbCtD
Selegiline—CYP2A6—Ifosfamide—hematologic cancer	0.0146	0.0272	CbGbCtD
Selegiline—CYP2E1—Thalidomide—hematologic cancer	0.011	0.0204	CbGbCtD
Selegiline—CYP2C9—Bexarotene—hematologic cancer	0.0107	0.0199	CbGbCtD
Selegiline—ABCB1—Lenalidomide—hematologic cancer	0.0104	0.0193	CbGbCtD
Selegiline—CYP2A6—Prednisolone—hematologic cancer	0.00975	0.0181	CbGbCtD
Selegiline—CYP2B6—Ifosfamide—hematologic cancer	0.00953	0.0177	CbGbCtD
Selegiline—CYP2E1—Dacarbazine—hematologic cancer	0.00943	0.0175	CbGbCtD
Selegiline—CYP2C8—Bortezomib—hematologic cancer	0.00941	0.0175	CbGbCtD
Selegiline—CYP2D6—Lomustine—hematologic cancer	0.0091	0.0169	CbGbCtD
Selegiline—CYP1A2—Carmustine—hematologic cancer	0.009	0.0167	CbGbCtD
Selegiline—CYP2C9—Idarubicin—hematologic cancer	0.00887	0.0165	CbGbCtD
Selegiline—CYP2B6—Nilotinib—hematologic cancer	0.00827	0.0154	CbGbCtD
Selegiline—CYP2D6—Idarubicin—hematologic cancer	0.00811	0.0151	CbGbCtD
Selegiline—CYP2C19—Bortezomib—hematologic cancer	0.00789	0.0147	CbGbCtD
Selegiline—CYP1A2—Methoxsalen—hematologic cancer	0.00766	0.0142	CbGbCtD
Selegiline—CYP2E1—Mitoxantrone—hematologic cancer	0.00732	0.0136	CbGbCtD
Selegiline—CYP1A2—Bortezomib—hematologic cancer	0.00728	0.0135	CbGbCtD
Selegiline—CYP2C8—Ifosfamide—hematologic cancer	0.00722	0.0134	CbGbCtD
Selegiline—CYP1A2—Daunorubicin—hematologic cancer	0.00697	0.0129	CbGbCtD
Selegiline—CYP2D6—Hydroxyurea—hematologic cancer	0.0069	0.0128	CbGbCtD
Selegiline—CYP2C19—Thalidomide—hematologic cancer	0.00688	0.0128	CbGbCtD
Selegiline—CYP1A2—Alitretinoin—hematologic cancer	0.00682	0.0127	CbGbCtD
Selegiline—CYP2C9—Bortezomib—hematologic cancer	0.00656	0.0122	CbGbCtD
Selegiline—CYP2C19—Teniposide—hematologic cancer	0.00656	0.0122	CbGbCtD
Selegiline—CYP1A2—Thalidomide—hematologic cancer	0.00634	0.0118	CbGbCtD
Selegiline—CYP2C8—Nilotinib—hematologic cancer	0.00626	0.0116	CbGbCtD
Selegiline—CYP3A4—Bexarotene—hematologic cancer	0.00622	0.0116	CbGbCtD
Selegiline—ABCB1—Daunorubicin—hematologic cancer	0.00609	0.0113	CbGbCtD
Selegiline—CYP2C19—Ifosfamide—hematologic cancer	0.00605	0.0112	CbGbCtD
Selegiline—CYP2D6—Bortezomib—hematologic cancer	0.006	0.0111	CbGbCtD
Selegiline—ABCB1—Alitretinoin—hematologic cancer	0.00597	0.0111	CbGbCtD
Selegiline—CYP3A4—Busulfan—hematologic cancer	0.00579	0.0107	CbGbCtD
Selegiline—CYP3A4—Lomustine—hematologic cancer	0.00579	0.0107	CbGbCtD
Selegiline—CYP2C19—Imatinib—hematologic cancer	0.00578	0.0107	CbGbCtD
Selegiline—CYP2A6—Dexamethasone—hematologic cancer	0.00575	0.0107	CbGbCtD
Selegiline—CYP2C9—Thalidomide—hematologic cancer	0.00572	0.0106	CbGbCtD
Selegiline—CYP2B6—Irinotecan—hematologic cancer	0.00568	0.0106	CbGbCtD
Selegiline—CYP1A2—Dacarbazine—hematologic cancer	0.00546	0.0101	CbGbCtD
Selegiline—CYP2C9—Teniposide—hematologic cancer	0.00545	0.0101	CbGbCtD
Selegiline—CYP1A2—Imatinib—hematologic cancer	0.00534	0.00991	CbGbCtD
Selegiline—CYP3A4—Thiotepa—hematologic cancer	0.00516	0.00958	CbGbCtD
Selegiline—CYP2C9—Ifosfamide—hematologic cancer	0.00503	0.00934	CbGbCtD
Selegiline—CYP2C9—Imatinib—hematologic cancer	0.00481	0.00893	CbGbCtD
Selegiline—ABCB1—Imatinib—hematologic cancer	0.00467	0.00866	CbGbCtD
Selegiline—CYP2B6—Cisplatin—hematologic cancer	0.00463	0.0086	CbGbCtD
Selegiline—CYP2E1—Etoposide—hematologic cancer	0.00462	0.00857	CbGbCtD
Selegiline—CYP2D6—Imatinib—hematologic cancer	0.0044	0.00816	CbGbCtD
Selegiline—CYP2C9—Nilotinib—hematologic cancer	0.00437	0.00811	CbGbCtD
Selegiline—CYP1A2—Dasatinib—hematologic cancer	0.00429	0.00796	CbGbCtD
Selegiline—ABCB1—Nilotinib—hematologic cancer	0.00424	0.00787	CbGbCtD
Selegiline—ABCB1—Vinorelbine—hematologic cancer	0.0042	0.00781	CbGbCtD
Selegiline—CYP3A4—Methoxsalen—hematologic cancer	0.00401	0.00745	CbGbCtD
Selegiline—CYP2D6—Nilotinib—hematologic cancer	0.00399	0.00742	CbGbCtD
Selegiline—CYP2D6—Vinorelbine—hematologic cancer	0.00396	0.00735	CbGbCtD
Selegiline—CYP3A4—Bortezomib—hematologic cancer	0.00382	0.00708	CbGbCtD
Selegiline—CYP2C19—Prednisone—hematologic cancer	0.00381	0.00707	CbGbCtD
Selegiline—CYP2E1—Dexamethasone—hematologic cancer	0.00379	0.00705	CbGbCtD
Selegiline—ABCB1—Dasatinib—hematologic cancer	0.00375	0.00696	CbGbCtD
Selegiline—CYP2B6—Dexamethasone—hematologic cancer	0.00374	0.00695	CbGbCtD
Selegiline—ABCB1—Mitoxantrone—hematologic cancer	0.0037	0.00687	CbGbCtD
Selegiline—CYP3A4—Daunorubicin—hematologic cancer	0.00365	0.00678	CbGbCtD
Selegiline—CYP2C8—Etoposide—hematologic cancer	0.00345	0.0064	CbGbCtD
Selegiline—ABCB1—Betamethasone—hematologic cancer	0.0033	0.00613	CbGbCtD
Selegiline—ABCB1—Gemcitabine—hematologic cancer	0.00327	0.00607	CbGbCtD
Selegiline—ABCB1—Prednisolone—hematologic cancer	0.00326	0.00604	CbGbCtD
Selegiline—CYP3A4—Cytarabine—hematologic cancer	0.00322	0.00598	CbGbCtD
Selegiline—CYP3A4—Teniposide—hematologic cancer	0.00317	0.00589	CbGbCtD
Selegiline—CYP2B6—Doxorubicin—hematologic cancer	0.00311	0.00577	CbGbCtD
Selegiline—ABCB1—Prednisone—hematologic cancer	0.00307	0.00571	CbGbCtD
Selegiline—CYP3A4—Ifosfamide—hematologic cancer	0.00293	0.00543	CbGbCtD
Selegiline—ABCB1—Irinotecan—hematologic cancer	0.00291	0.00541	CbGbCtD
Selegiline—CYP2C8—Dexamethasone—hematologic cancer	0.00284	0.00526	CbGbCtD
Selegiline—CYP3A4—Imatinib—hematologic cancer	0.0028	0.00519	CbGbCtD
Selegiline—CYP1A2—Etoposide—hematologic cancer	0.00267	0.00496	CbGbCtD
Selegiline—CYP3A4—Ruxolitinib—hematologic cancer	0.00263	0.00489	CbGbCtD
Selegiline—ABCB1—Vinblastine—hematologic cancer	0.00259	0.00481	CbGbCtD
Selegiline—ABCB1—Vincristine—hematologic cancer	0.00255	0.00473	CbGbCtD
Selegiline—CYP3A4—Nilotinib—hematologic cancer	0.00254	0.00472	CbGbCtD
Selegiline—CYP3A4—Vinorelbine—hematologic cancer	0.00252	0.00468	CbGbCtD
Selegiline—CYP2C9—Cisplatin—hematologic cancer	0.00245	0.00454	CbGbCtD
Selegiline—CYP2D6—Vinblastine—hematologic cancer	0.00244	0.00453	CbGbCtD
Selegiline—CYP2C19—Dexamethasone—hematologic cancer	0.00238	0.00442	CbGbCtD
Selegiline—ABCB1—Cisplatin—hematologic cancer	0.00238	0.00441	CbGbCtD
Selegiline—ABCB1—Etoposide—hematologic cancer	0.00233	0.00433	CbGbCtD
Selegiline—CYP3A4—Triamcinolone—hematologic cancer	0.0023	0.00428	CbGbCtD
Selegiline—CYP3A4—Dasatinib—hematologic cancer	0.00225	0.00417	CbGbCtD
Selegiline—CYP3A4—Mitoxantrone—hematologic cancer	0.00222	0.00412	CbGbCtD
Selegiline—CYP2C9—Dexamethasone—hematologic cancer	0.00198	0.00367	CbGbCtD
Selegiline—CYP3A4—Betamethasone—hematologic cancer	0.00198	0.00367	CbGbCtD
Selegiline—CYP3A4—Prednisolone—hematologic cancer	0.00195	0.00362	CbGbCtD
Selegiline—ABCB1—Dexamethasone—hematologic cancer	0.00192	0.00356	CbGbCtD
Selegiline—CYP3A4—Prednisone—hematologic cancer	0.00184	0.00342	CbGbCtD
Selegiline—CYP2D6—Dexamethasone—hematologic cancer	0.00181	0.00336	CbGbCtD
Selegiline—CYP3A4—Irinotecan—hematologic cancer	0.00175	0.00324	CbGbCtD
Selegiline—ABCB1—Doxorubicin—hematologic cancer	0.00159	0.00296	CbGbCtD
Selegiline—CYP3A4—Vinblastine—hematologic cancer	0.00155	0.00288	CbGbCtD
Selegiline—ABCB1—Methotrexate—hematologic cancer	0.00154	0.00286	CbGbCtD
Selegiline—CYP3A4—Vincristine—hematologic cancer	0.00153	0.00283	CbGbCtD
Selegiline—CYP2D6—Doxorubicin—hematologic cancer	0.0015	0.00279	CbGbCtD
Selegiline—CYP3A4—Etoposide—hematologic cancer	0.0014	0.0026	CbGbCtD
Selegiline—CYP3A4—Dexamethasone—hematologic cancer	0.00115	0.00213	CbGbCtD
Selegiline—CYP3A4—Doxorubicin—hematologic cancer	0.000954	0.00177	CbGbCtD
Selegiline—MAOB—hematopoietic system—hematologic cancer	0.000606	0.049	CbGeAlD
Selegiline—CYP2C19—hematopoietic system—hematologic cancer	0.000528	0.0427	CbGeAlD
Selegiline—MAOA—hematopoietic system—hematologic cancer	0.000517	0.0418	CbGeAlD
Selegiline—CYP2A6—lung—hematologic cancer	0.000477	0.0386	CbGeAlD
Selegiline—CYP2C8—hematopoietic system—hematologic cancer	0.000461	0.0373	CbGeAlD
Selegiline—CYP1A2—hematopoietic system—hematologic cancer	0.000431	0.0349	CbGeAlD
Selegiline—CYP2B6—hematopoietic system—hematologic cancer	0.000413	0.0334	CbGeAlD
Selegiline—CYP2C9—hematopoietic system—hematologic cancer	0.000409	0.0331	CbGeAlD
Selegiline—MAOB—blood—hematologic cancer	0.000401	0.0325	CbGeAlD
Selegiline—CYP2E1—hematopoietic system—hematologic cancer	0.000388	0.0314	CbGeAlD
Selegiline—MAOB—lung—hematologic cancer	0.000352	0.0285	CbGeAlD
Selegiline—CYP2C19—blood—hematologic cancer	0.00035	0.0283	CbGeAlD
Selegiline—MAOA—blood—hematologic cancer	0.000343	0.0277	CbGeAlD
Selegiline—MAOB—testis—hematologic cancer	0.000332	0.0269	CbGeAlD
Selegiline—CYP2B6—gonad—hematologic cancer	0.000314	0.0254	CbGeAlD
Selegiline—CYP3A4—hematopoietic system—hematologic cancer	0.000312	0.0252	CbGeAlD
Selegiline—CYP2D6—hematopoietic system—hematologic cancer	0.000307	0.0248	CbGeAlD
Selegiline—CYP2C8—blood—hematologic cancer	0.000305	0.0247	CbGeAlD
Selegiline—MAOA—lung—hematologic cancer	0.0003	0.0243	CbGeAlD
Selegiline—CYP1A2—blood—hematologic cancer	0.000286	0.0231	CbGeAlD
Selegiline—MAOA—testis—hematologic cancer	0.000283	0.0229	CbGeAlD
Selegiline—CYP2B6—blood—hematologic cancer	0.000274	0.0222	CbGeAlD
Selegiline—CYP2C9—blood—hematologic cancer	0.000271	0.0219	CbGeAlD
Selegiline—CYP2E1—blood—hematologic cancer	0.000257	0.0208	CbGeAlD
Selegiline—CYP2C8—testis—hematologic cancer	0.000253	0.0204	CbGeAlD
Selegiline—CYP1A2—lung—hematologic cancer	0.000251	0.0203	CbGeAlD
Selegiline—MAOB—lymph node—hematologic cancer	0.000241	0.0195	CbGeAlD
Selegiline—CYP2B6—lung—hematologic cancer	0.00024	0.0194	CbGeAlD
Selegiline—Pseudoephedrine—IL2—hematologic cancer	0.00024	0.748	CrCbGaD
Selegiline—CYP2B6—testis—hematologic cancer	0.000227	0.0183	CbGeAlD
Selegiline—CYP2E1—lung—hematologic cancer	0.000225	0.0182	CbGeAlD
Selegiline—ABCB1—hematopoietic system—hematologic cancer	0.000221	0.0179	CbGeAlD
Selegiline—CYP2E1—testis—hematologic cancer	0.000213	0.0172	CbGeAlD
Selegiline—CYP3A4—blood—hematologic cancer	0.000207	0.0167	CbGeAlD
Selegiline—MAOA—lymph node—hematologic cancer	0.000205	0.0166	CbGeAlD
Selegiline—CYP2D6—blood—hematologic cancer	0.000204	0.0165	CbGeAlD
Selegiline—CYP2D6—testis—hematologic cancer	0.000168	0.0136	CbGeAlD
Selegiline—ABCB1—gonad—hematologic cancer	0.000168	0.0136	CbGeAlD
Selegiline—ABCB1—blood—hematologic cancer	0.000146	0.0118	CbGeAlD
Selegiline—ABCB1—bone marrow—hematologic cancer	0.000142	0.0115	CbGeAlD
Selegiline—ABCB1—lung—hematologic cancer	0.000128	0.0104	CbGeAlD
Selegiline—ABCB1—testis—hematologic cancer	0.000121	0.00979	CbGeAlD
Selegiline—ABCB1—lymph node—hematologic cancer	8.78e-05	0.0071	CbGeAlD
Selegiline—Pseudoephedrine—TNF—hematologic cancer	8.1e-05	0.252	CrCbGaD
Selegiline—Tinnitus—Doxorubicin—hematologic cancer	1.09e-05	4.7e-05	CcSEcCtD
Selegiline—Anaemia—Methotrexate—hematologic cancer	1.09e-05	4.68e-05	CcSEcCtD
Selegiline—Feeling abnormal—Dexamethasone—hematologic cancer	1.09e-05	4.68e-05	CcSEcCtD
Selegiline—Feeling abnormal—Betamethasone—hematologic cancer	1.09e-05	4.68e-05	CcSEcCtD
Selegiline—Flushing—Doxorubicin—hematologic cancer	1.09e-05	4.68e-05	CcSEcCtD
Selegiline—Flatulence—Epirubicin—hematologic cancer	1.08e-05	4.67e-05	CcSEcCtD
Selegiline—Tension—Epirubicin—hematologic cancer	1.08e-05	4.65e-05	CcSEcCtD
Selegiline—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.08e-05	4.65e-05	CcSEcCtD
Selegiline—Gastrointestinal pain—Betamethasone—hematologic cancer	1.08e-05	4.65e-05	CcSEcCtD
Selegiline—Dysgeusia—Epirubicin—hematologic cancer	1.08e-05	4.64e-05	CcSEcCtD
Selegiline—Hypersensitivity—Triamcinolone—hematologic cancer	1.07e-05	4.61e-05	CcSEcCtD
Selegiline—Nervousness—Epirubicin—hematologic cancer	1.07e-05	4.61e-05	CcSEcCtD
Selegiline—Back pain—Epirubicin—hematologic cancer	1.06e-05	4.59e-05	CcSEcCtD
Selegiline—Angiopathy—Doxorubicin—hematologic cancer	1.06e-05	4.57e-05	CcSEcCtD
Selegiline—Malaise—Methotrexate—hematologic cancer	1.06e-05	4.57e-05	CcSEcCtD
Selegiline—Dizziness—Etoposide—hematologic cancer	1.06e-05	4.57e-05	CcSEcCtD
Selegiline—Muscle spasms—Epirubicin—hematologic cancer	1.06e-05	4.56e-05	CcSEcCtD
Selegiline—Vertigo—Methotrexate—hematologic cancer	1.06e-05	4.55e-05	CcSEcCtD
Selegiline—Leukopenia—Methotrexate—hematologic cancer	1.05e-05	4.54e-05	CcSEcCtD
Selegiline—Chills—Doxorubicin—hematologic cancer	1.05e-05	4.52e-05	CcSEcCtD
Selegiline—Urticaria—Dexamethasone—hematologic cancer	1.05e-05	4.51e-05	CcSEcCtD
Selegiline—Urticaria—Betamethasone—hematologic cancer	1.05e-05	4.51e-05	CcSEcCtD
Selegiline—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.05e-05	4.51e-05	CcSEcCtD
Selegiline—Dizziness—Prednisolone—hematologic cancer	1.05e-05	4.5e-05	CcSEcCtD
Selegiline—Arrhythmia—Doxorubicin—hematologic cancer	1.05e-05	4.5e-05	CcSEcCtD
Selegiline—Asthenia—Triamcinolone—hematologic cancer	1.04e-05	4.49e-05	CcSEcCtD
Selegiline—Abdominal pain—Dexamethasone—hematologic cancer	1.04e-05	4.49e-05	CcSEcCtD
Selegiline—Body temperature increased—Betamethasone—hematologic cancer	1.04e-05	4.49e-05	CcSEcCtD
Selegiline—Body temperature increased—Dexamethasone—hematologic cancer	1.04e-05	4.49e-05	CcSEcCtD
Selegiline—Abdominal pain—Betamethasone—hematologic cancer	1.04e-05	4.49e-05	CcSEcCtD
Selegiline—Nausea—Cisplatin—hematologic cancer	1.04e-05	4.48e-05	CcSEcCtD
Selegiline—Insomnia—Prednisone—hematologic cancer	1.04e-05	4.48e-05	CcSEcCtD
Selegiline—Vision blurred—Epirubicin—hematologic cancer	1.04e-05	4.47e-05	CcSEcCtD
Selegiline—Alopecia—Doxorubicin—hematologic cancer	1.03e-05	4.45e-05	CcSEcCtD
Selegiline—Paraesthesia—Prednisone—hematologic cancer	1.03e-05	4.44e-05	CcSEcCtD
Selegiline—Pruritus—Triamcinolone—hematologic cancer	1.03e-05	4.43e-05	CcSEcCtD
Selegiline—Cough—Methotrexate—hematologic cancer	1.03e-05	4.42e-05	CcSEcCtD
Selegiline—Mental disorder—Doxorubicin—hematologic cancer	1.03e-05	4.42e-05	CcSEcCtD
Selegiline—Ill-defined disorder—Epirubicin—hematologic cancer	1.02e-05	4.4e-05	CcSEcCtD
Selegiline—Convulsion—Methotrexate—hematologic cancer	1.02e-05	4.39e-05	CcSEcCtD
Selegiline—Vomiting—Etoposide—hematologic cancer	1.02e-05	4.39e-05	CcSEcCtD
Selegiline—Malnutrition—Doxorubicin—hematologic cancer	1.02e-05	4.39e-05	CcSEcCtD
Selegiline—Erythema—Doxorubicin—hematologic cancer	1.02e-05	4.39e-05	CcSEcCtD
Selegiline—Anaemia—Epirubicin—hematologic cancer	1.02e-05	4.38e-05	CcSEcCtD
Selegiline—Agitation—Epirubicin—hematologic cancer	1.01e-05	4.36e-05	CcSEcCtD
Selegiline—Dyspepsia—Prednisone—hematologic cancer	1.01e-05	4.36e-05	CcSEcCtD
Selegiline—Rash—Etoposide—hematologic cancer	1.01e-05	4.35e-05	CcSEcCtD
Selegiline—Dermatitis—Etoposide—hematologic cancer	1.01e-05	4.35e-05	CcSEcCtD
Selegiline—Headache—Etoposide—hematologic cancer	1e-05	4.33e-05	CcSEcCtD
Selegiline—Flatulence—Doxorubicin—hematologic cancer	1e-05	4.32e-05	CcSEcCtD
Selegiline—Myalgia—Methotrexate—hematologic cancer	1e-05	4.31e-05	CcSEcCtD
Selegiline—Chest pain—Methotrexate—hematologic cancer	1e-05	4.31e-05	CcSEcCtD
Selegiline—Arthralgia—Methotrexate—hematologic cancer	1e-05	4.31e-05	CcSEcCtD
Selegiline—Tension—Doxorubicin—hematologic cancer	9.99e-06	4.31e-05	CcSEcCtD
Selegiline—Decreased appetite—Prednisone—hematologic cancer	9.99e-06	4.3e-05	CcSEcCtD
Selegiline—Dysgeusia—Doxorubicin—hematologic cancer	9.97e-06	4.3e-05	CcSEcCtD
Selegiline—Rash—Prednisolone—hematologic cancer	9.97e-06	4.29e-05	CcSEcCtD
Selegiline—Dermatitis—Prednisolone—hematologic cancer	9.96e-06	4.29e-05	CcSEcCtD
Selegiline—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	9.94e-06	4.28e-05	CcSEcCtD
Selegiline—Malaise—Epirubicin—hematologic cancer	9.93e-06	4.28e-05	CcSEcCtD
Selegiline—Fatigue—Prednisone—hematologic cancer	9.9e-06	4.27e-05	CcSEcCtD
Selegiline—Headache—Prednisolone—hematologic cancer	9.9e-06	4.27e-05	CcSEcCtD
Selegiline—Discomfort—Methotrexate—hematologic cancer	9.89e-06	4.26e-05	CcSEcCtD
Selegiline—Nervousness—Doxorubicin—hematologic cancer	9.89e-06	4.26e-05	CcSEcCtD
Selegiline—Vertigo—Epirubicin—hematologic cancer	9.89e-06	4.26e-05	CcSEcCtD
Selegiline—Syncope—Epirubicin—hematologic cancer	9.87e-06	4.25e-05	CcSEcCtD
Selegiline—Leukopenia—Epirubicin—hematologic cancer	9.85e-06	4.25e-05	CcSEcCtD
Selegiline—Back pain—Doxorubicin—hematologic cancer	9.85e-06	4.24e-05	CcSEcCtD
Selegiline—Constipation—Prednisone—hematologic cancer	9.82e-06	4.23e-05	CcSEcCtD
Selegiline—Muscle spasms—Doxorubicin—hematologic cancer	9.79e-06	4.22e-05	CcSEcCtD
Selegiline—Palpitations—Epirubicin—hematologic cancer	9.73e-06	4.19e-05	CcSEcCtD
Selegiline—Confusional state—Methotrexate—hematologic cancer	9.68e-06	4.17e-05	CcSEcCtD
Selegiline—Loss of consciousness—Epirubicin—hematologic cancer	9.67e-06	4.17e-05	CcSEcCtD
Selegiline—Dizziness—Triamcinolone—hematologic cancer	9.61e-06	4.14e-05	CcSEcCtD
Selegiline—Cough—Epirubicin—hematologic cancer	9.61e-06	4.14e-05	CcSEcCtD
Selegiline—Vision blurred—Doxorubicin—hematologic cancer	9.6e-06	4.14e-05	CcSEcCtD
Selegiline—Convulsion—Epirubicin—hematologic cancer	9.54e-06	4.11e-05	CcSEcCtD
Selegiline—Infection—Methotrexate—hematologic cancer	9.54e-06	4.11e-05	CcSEcCtD
Selegiline—Nausea—Etoposide—hematologic cancer	9.52e-06	4.1e-05	CcSEcCtD
Selegiline—Hypertension—Epirubicin—hematologic cancer	9.5e-06	4.09e-05	CcSEcCtD
Selegiline—Feeling abnormal—Prednisone—hematologic cancer	9.47e-06	4.08e-05	CcSEcCtD
Selegiline—Asthenia—Betamethasone—hematologic cancer	9.46e-06	4.08e-05	CcSEcCtD
Selegiline—Asthenia—Dexamethasone—hematologic cancer	9.46e-06	4.08e-05	CcSEcCtD
Selegiline—Ill-defined disorder—Doxorubicin—hematologic cancer	9.45e-06	4.07e-05	CcSEcCtD
Selegiline—Nervous system disorder—Methotrexate—hematologic cancer	9.41e-06	4.06e-05	CcSEcCtD
Selegiline—Anaemia—Doxorubicin—hematologic cancer	9.41e-06	4.06e-05	CcSEcCtD
Selegiline—Thrombocytopenia—Methotrexate—hematologic cancer	9.4e-06	4.05e-05	CcSEcCtD
Selegiline—Gastrointestinal pain—Prednisone—hematologic cancer	9.39e-06	4.05e-05	CcSEcCtD
Selegiline—Nausea—Prednisolone—hematologic cancer	9.39e-06	4.05e-05	CcSEcCtD
Selegiline—Chest pain—Epirubicin—hematologic cancer	9.37e-06	4.04e-05	CcSEcCtD
Selegiline—Arthralgia—Epirubicin—hematologic cancer	9.37e-06	4.04e-05	CcSEcCtD
Selegiline—Myalgia—Epirubicin—hematologic cancer	9.37e-06	4.04e-05	CcSEcCtD
Selegiline—Agitation—Doxorubicin—hematologic cancer	9.36e-06	4.03e-05	CcSEcCtD
Selegiline—Anxiety—Epirubicin—hematologic cancer	9.34e-06	4.02e-05	CcSEcCtD
Selegiline—Pruritus—Betamethasone—hematologic cancer	9.33e-06	4.02e-05	CcSEcCtD
Selegiline—Pruritus—Dexamethasone—hematologic cancer	9.33e-06	4.02e-05	CcSEcCtD
Selegiline—Skin disorder—Methotrexate—hematologic cancer	9.32e-06	4.02e-05	CcSEcCtD
Selegiline—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	9.31e-06	4.01e-05	CcSEcCtD
Selegiline—Hyperhidrosis—Methotrexate—hematologic cancer	9.28e-06	4e-05	CcSEcCtD
Selegiline—Discomfort—Epirubicin—hematologic cancer	9.26e-06	3.99e-05	CcSEcCtD
Selegiline—Vomiting—Triamcinolone—hematologic cancer	9.24e-06	3.98e-05	CcSEcCtD
Selegiline—Malaise—Doxorubicin—hematologic cancer	9.18e-06	3.96e-05	CcSEcCtD
Selegiline—Rash—Triamcinolone—hematologic cancer	9.17e-06	3.95e-05	CcSEcCtD
Selegiline—Dry mouth—Epirubicin—hematologic cancer	9.17e-06	3.95e-05	CcSEcCtD
Selegiline—Dermatitis—Triamcinolone—hematologic cancer	9.16e-06	3.95e-05	CcSEcCtD
Selegiline—Vertigo—Doxorubicin—hematologic cancer	9.15e-06	3.94e-05	CcSEcCtD
Selegiline—Anorexia—Methotrexate—hematologic cancer	9.15e-06	3.94e-05	CcSEcCtD
Selegiline—Syncope—Doxorubicin—hematologic cancer	9.13e-06	3.94e-05	CcSEcCtD
Selegiline—Urticaria—Prednisone—hematologic cancer	9.13e-06	3.93e-05	CcSEcCtD
Selegiline—Leukopenia—Doxorubicin—hematologic cancer	9.12e-06	3.93e-05	CcSEcCtD
Selegiline—Headache—Triamcinolone—hematologic cancer	9.11e-06	3.92e-05	CcSEcCtD
Selegiline—Abdominal pain—Prednisone—hematologic cancer	9.08e-06	3.91e-05	CcSEcCtD
Selegiline—Body temperature increased—Prednisone—hematologic cancer	9.08e-06	3.91e-05	CcSEcCtD
Selegiline—Confusional state—Epirubicin—hematologic cancer	9.06e-06	3.9e-05	CcSEcCtD
Selegiline—Diarrhoea—Betamethasone—hematologic cancer	9.02e-06	3.89e-05	CcSEcCtD
Selegiline—Diarrhoea—Dexamethasone—hematologic cancer	9.02e-06	3.89e-05	CcSEcCtD
Selegiline—Palpitations—Doxorubicin—hematologic cancer	9e-06	3.88e-05	CcSEcCtD
Selegiline—Oedema—Epirubicin—hematologic cancer	8.98e-06	3.87e-05	CcSEcCtD
Selegiline—Hypotension—Methotrexate—hematologic cancer	8.97e-06	3.86e-05	CcSEcCtD
Selegiline—Loss of consciousness—Doxorubicin—hematologic cancer	8.95e-06	3.86e-05	CcSEcCtD
Selegiline—Infection—Epirubicin—hematologic cancer	8.92e-06	3.85e-05	CcSEcCtD
Selegiline—Cough—Doxorubicin—hematologic cancer	8.89e-06	3.83e-05	CcSEcCtD
Selegiline—Shock—Epirubicin—hematologic cancer	8.84e-06	3.81e-05	CcSEcCtD
Selegiline—Convulsion—Doxorubicin—hematologic cancer	8.82e-06	3.8e-05	CcSEcCtD
Selegiline—Nervous system disorder—Epirubicin—hematologic cancer	8.81e-06	3.8e-05	CcSEcCtD
Selegiline—Thrombocytopenia—Epirubicin—hematologic cancer	8.8e-06	3.79e-05	CcSEcCtD
Selegiline—Hypertension—Doxorubicin—hematologic cancer	8.79e-06	3.79e-05	CcSEcCtD
Selegiline—Tachycardia—Epirubicin—hematologic cancer	8.77e-06	3.78e-05	CcSEcCtD
Selegiline—Musculoskeletal discomfort—Methotrexate—hematologic cancer	8.75e-06	3.77e-05	CcSEcCtD
Selegiline—Skin disorder—Epirubicin—hematologic cancer	8.73e-06	3.76e-05	CcSEcCtD
Selegiline—Dizziness—Betamethasone—hematologic cancer	8.72e-06	3.76e-05	CcSEcCtD
Selegiline—Dizziness—Dexamethasone—hematologic cancer	8.72e-06	3.76e-05	CcSEcCtD
Selegiline—Hyperhidrosis—Epirubicin—hematologic cancer	8.68e-06	3.74e-05	CcSEcCtD
Selegiline—Insomnia—Methotrexate—hematologic cancer	8.68e-06	3.74e-05	CcSEcCtD
Selegiline—Myalgia—Doxorubicin—hematologic cancer	8.67e-06	3.74e-05	CcSEcCtD
Selegiline—Arthralgia—Doxorubicin—hematologic cancer	8.67e-06	3.74e-05	CcSEcCtD
Selegiline—Chest pain—Doxorubicin—hematologic cancer	8.67e-06	3.74e-05	CcSEcCtD
Selegiline—Anxiety—Doxorubicin—hematologic cancer	8.64e-06	3.72e-05	CcSEcCtD
Selegiline—Nausea—Triamcinolone—hematologic cancer	8.63e-06	3.72e-05	CcSEcCtD
Selegiline—Paraesthesia—Methotrexate—hematologic cancer	8.62e-06	3.71e-05	CcSEcCtD
Selegiline—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	8.61e-06	3.71e-05	CcSEcCtD
Selegiline—Discomfort—Doxorubicin—hematologic cancer	8.57e-06	3.69e-05	CcSEcCtD
Selegiline—Anorexia—Epirubicin—hematologic cancer	8.56e-06	3.69e-05	CcSEcCtD
Selegiline—Dyspnoea—Methotrexate—hematologic cancer	8.56e-06	3.69e-05	CcSEcCtD
Selegiline—Somnolence—Methotrexate—hematologic cancer	8.53e-06	3.68e-05	CcSEcCtD
Selegiline—Dry mouth—Doxorubicin—hematologic cancer	8.48e-06	3.65e-05	CcSEcCtD
Selegiline—Hypersensitivity—Prednisone—hematologic cancer	8.46e-06	3.65e-05	CcSEcCtD
Selegiline—Dyspepsia—Methotrexate—hematologic cancer	8.45e-06	3.64e-05	CcSEcCtD
Selegiline—Hypotension—Epirubicin—hematologic cancer	8.39e-06	3.62e-05	CcSEcCtD
Selegiline—Vomiting—Dexamethasone—hematologic cancer	8.39e-06	3.61e-05	CcSEcCtD
Selegiline—Vomiting—Betamethasone—hematologic cancer	8.39e-06	3.61e-05	CcSEcCtD
Selegiline—Confusional state—Doxorubicin—hematologic cancer	8.38e-06	3.61e-05	CcSEcCtD
Selegiline—Decreased appetite—Methotrexate—hematologic cancer	8.34e-06	3.6e-05	CcSEcCtD
Selegiline—Rash—Betamethasone—hematologic cancer	8.32e-06	3.58e-05	CcSEcCtD
Selegiline—Rash—Dexamethasone—hematologic cancer	8.32e-06	3.58e-05	CcSEcCtD
Selegiline—Oedema—Doxorubicin—hematologic cancer	8.31e-06	3.58e-05	CcSEcCtD
Selegiline—Dermatitis—Betamethasone—hematologic cancer	8.31e-06	3.58e-05	CcSEcCtD
Selegiline—Dermatitis—Dexamethasone—hematologic cancer	8.31e-06	3.58e-05	CcSEcCtD
Selegiline—Gastrointestinal disorder—Methotrexate—hematologic cancer	8.29e-06	3.57e-05	CcSEcCtD
Selegiline—Fatigue—Methotrexate—hematologic cancer	8.28e-06	3.57e-05	CcSEcCtD
Selegiline—Headache—Betamethasone—hematologic cancer	8.26e-06	3.56e-05	CcSEcCtD
Selegiline—Headache—Dexamethasone—hematologic cancer	8.26e-06	3.56e-05	CcSEcCtD
Selegiline—Infection—Doxorubicin—hematologic cancer	8.26e-06	3.56e-05	CcSEcCtD
Selegiline—Asthenia—Prednisone—hematologic cancer	8.24e-06	3.55e-05	CcSEcCtD
Selegiline—Pain—Methotrexate—hematologic cancer	8.21e-06	3.54e-05	CcSEcCtD
Selegiline—Musculoskeletal discomfort—Epirubicin—hematologic cancer	8.18e-06	3.53e-05	CcSEcCtD
Selegiline—Shock—Doxorubicin—hematologic cancer	8.18e-06	3.52e-05	CcSEcCtD
Selegiline—Nervous system disorder—Doxorubicin—hematologic cancer	8.15e-06	3.51e-05	CcSEcCtD
Selegiline—Thrombocytopenia—Doxorubicin—hematologic cancer	8.14e-06	3.51e-05	CcSEcCtD
Selegiline—Pruritus—Prednisone—hematologic cancer	8.13e-06	3.5e-05	CcSEcCtD
Selegiline—Insomnia—Epirubicin—hematologic cancer	8.13e-06	3.5e-05	CcSEcCtD
Selegiline—Tachycardia—Doxorubicin—hematologic cancer	8.11e-06	3.5e-05	CcSEcCtD
Selegiline—Skin disorder—Doxorubicin—hematologic cancer	8.07e-06	3.48e-05	CcSEcCtD
Selegiline—Paraesthesia—Epirubicin—hematologic cancer	8.07e-06	3.48e-05	CcSEcCtD
Selegiline—Hyperhidrosis—Doxorubicin—hematologic cancer	8.04e-06	3.46e-05	CcSEcCtD
Selegiline—Dyspnoea—Epirubicin—hematologic cancer	8.01e-06	3.45e-05	CcSEcCtD
Selegiline—Somnolence—Epirubicin—hematologic cancer	7.99e-06	3.44e-05	CcSEcCtD
Selegiline—Anorexia—Doxorubicin—hematologic cancer	7.92e-06	3.41e-05	CcSEcCtD
Selegiline—Feeling abnormal—Methotrexate—hematologic cancer	7.91e-06	3.41e-05	CcSEcCtD
Selegiline—Dyspepsia—Epirubicin—hematologic cancer	7.91e-06	3.41e-05	CcSEcCtD
Selegiline—Diarrhoea—Prednisone—hematologic cancer	7.86e-06	3.39e-05	CcSEcCtD
Selegiline—Gastrointestinal pain—Methotrexate—hematologic cancer	7.85e-06	3.38e-05	CcSEcCtD
Selegiline—Nausea—Betamethasone—hematologic cancer	7.83e-06	3.38e-05	CcSEcCtD
Selegiline—Nausea—Dexamethasone—hematologic cancer	7.83e-06	3.38e-05	CcSEcCtD
Selegiline—Decreased appetite—Epirubicin—hematologic cancer	7.81e-06	3.36e-05	CcSEcCtD
Selegiline—Hypotension—Doxorubicin—hematologic cancer	7.77e-06	3.35e-05	CcSEcCtD
Selegiline—Gastrointestinal disorder—Epirubicin—hematologic cancer	7.76e-06	3.34e-05	CcSEcCtD
Selegiline—Fatigue—Epirubicin—hematologic cancer	7.75e-06	3.34e-05	CcSEcCtD
Selegiline—Constipation—Epirubicin—hematologic cancer	7.68e-06	3.31e-05	CcSEcCtD
Selegiline—Pain—Epirubicin—hematologic cancer	7.68e-06	3.31e-05	CcSEcCtD
Selegiline—Urticaria—Methotrexate—hematologic cancer	7.63e-06	3.29e-05	CcSEcCtD
Selegiline—Dizziness—Prednisone—hematologic cancer	7.6e-06	3.27e-05	CcSEcCtD
Selegiline—Abdominal pain—Methotrexate—hematologic cancer	7.59e-06	3.27e-05	CcSEcCtD
Selegiline—Body temperature increased—Methotrexate—hematologic cancer	7.59e-06	3.27e-05	CcSEcCtD
Selegiline—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	7.57e-06	3.26e-05	CcSEcCtD
Selegiline—Insomnia—Doxorubicin—hematologic cancer	7.52e-06	3.24e-05	CcSEcCtD
Selegiline—Paraesthesia—Doxorubicin—hematologic cancer	7.46e-06	3.22e-05	CcSEcCtD
Selegiline—Dyspnoea—Doxorubicin—hematologic cancer	7.41e-06	3.19e-05	CcSEcCtD
Selegiline—Feeling abnormal—Epirubicin—hematologic cancer	7.4e-06	3.19e-05	CcSEcCtD
Selegiline—Somnolence—Doxorubicin—hematologic cancer	7.39e-06	3.18e-05	CcSEcCtD
Selegiline—Gastrointestinal pain—Epirubicin—hematologic cancer	7.35e-06	3.17e-05	CcSEcCtD
Selegiline—Dyspepsia—Doxorubicin—hematologic cancer	7.32e-06	3.15e-05	CcSEcCtD
Selegiline—Vomiting—Prednisone—hematologic cancer	7.3e-06	3.15e-05	CcSEcCtD
Selegiline—Rash—Prednisone—hematologic cancer	7.24e-06	3.12e-05	CcSEcCtD
Selegiline—Dermatitis—Prednisone—hematologic cancer	7.24e-06	3.12e-05	CcSEcCtD
Selegiline—Decreased appetite—Doxorubicin—hematologic cancer	7.23e-06	3.11e-05	CcSEcCtD
Selegiline—Headache—Prednisone—hematologic cancer	7.2e-06	3.1e-05	CcSEcCtD
Selegiline—Gastrointestinal disorder—Doxorubicin—hematologic cancer	7.18e-06	3.09e-05	CcSEcCtD
Selegiline—Fatigue—Doxorubicin—hematologic cancer	7.17e-06	3.09e-05	CcSEcCtD
Selegiline—Urticaria—Epirubicin—hematologic cancer	7.14e-06	3.07e-05	CcSEcCtD
Selegiline—Pain—Doxorubicin—hematologic cancer	7.11e-06	3.06e-05	CcSEcCtD
Selegiline—Constipation—Doxorubicin—hematologic cancer	7.11e-06	3.06e-05	CcSEcCtD
Selegiline—Abdominal pain—Epirubicin—hematologic cancer	7.1e-06	3.06e-05	CcSEcCtD
Selegiline—Body temperature increased—Epirubicin—hematologic cancer	7.1e-06	3.06e-05	CcSEcCtD
Selegiline—Hypersensitivity—Methotrexate—hematologic cancer	7.07e-06	3.05e-05	CcSEcCtD
Selegiline—Asthenia—Methotrexate—hematologic cancer	6.89e-06	2.97e-05	CcSEcCtD
Selegiline—Feeling abnormal—Doxorubicin—hematologic cancer	6.85e-06	2.95e-05	CcSEcCtD
Selegiline—Nausea—Prednisone—hematologic cancer	6.82e-06	2.94e-05	CcSEcCtD
Selegiline—Gastrointestinal pain—Doxorubicin—hematologic cancer	6.8e-06	2.93e-05	CcSEcCtD
Selegiline—Pruritus—Methotrexate—hematologic cancer	6.79e-06	2.93e-05	CcSEcCtD
Selegiline—Hypersensitivity—Epirubicin—hematologic cancer	6.62e-06	2.85e-05	CcSEcCtD
Selegiline—Urticaria—Doxorubicin—hematologic cancer	6.6e-06	2.85e-05	CcSEcCtD
Selegiline—Abdominal pain—Doxorubicin—hematologic cancer	6.57e-06	2.83e-05	CcSEcCtD
Selegiline—Body temperature increased—Doxorubicin—hematologic cancer	6.57e-06	2.83e-05	CcSEcCtD
Selegiline—Diarrhoea—Methotrexate—hematologic cancer	6.57e-06	2.83e-05	CcSEcCtD
Selegiline—Asthenia—Epirubicin—hematologic cancer	6.45e-06	2.78e-05	CcSEcCtD
Selegiline—Pruritus—Epirubicin—hematologic cancer	6.36e-06	2.74e-05	CcSEcCtD
Selegiline—Dizziness—Methotrexate—hematologic cancer	6.35e-06	2.74e-05	CcSEcCtD
Selegiline—Diarrhoea—Epirubicin—hematologic cancer	6.15e-06	2.65e-05	CcSEcCtD
Selegiline—Hypersensitivity—Doxorubicin—hematologic cancer	6.12e-06	2.64e-05	CcSEcCtD
Selegiline—Vomiting—Methotrexate—hematologic cancer	6.1e-06	2.63e-05	CcSEcCtD
Selegiline—Rash—Methotrexate—hematologic cancer	6.05e-06	2.61e-05	CcSEcCtD
Selegiline—Dermatitis—Methotrexate—hematologic cancer	6.05e-06	2.61e-05	CcSEcCtD
Selegiline—Headache—Methotrexate—hematologic cancer	6.01e-06	2.59e-05	CcSEcCtD
Selegiline—Asthenia—Doxorubicin—hematologic cancer	5.96e-06	2.57e-05	CcSEcCtD
Selegiline—Dizziness—Epirubicin—hematologic cancer	5.94e-06	2.56e-05	CcSEcCtD
Selegiline—Pruritus—Doxorubicin—hematologic cancer	5.88e-06	2.53e-05	CcSEcCtD
Selegiline—Vomiting—Epirubicin—hematologic cancer	5.71e-06	2.46e-05	CcSEcCtD
Selegiline—Nausea—Methotrexate—hematologic cancer	5.7e-06	2.46e-05	CcSEcCtD
Selegiline—Diarrhoea—Doxorubicin—hematologic cancer	5.69e-06	2.45e-05	CcSEcCtD
Selegiline—Rash—Epirubicin—hematologic cancer	5.66e-06	2.44e-05	CcSEcCtD
Selegiline—Dermatitis—Epirubicin—hematologic cancer	5.66e-06	2.44e-05	CcSEcCtD
Selegiline—Headache—Epirubicin—hematologic cancer	5.63e-06	2.42e-05	CcSEcCtD
Selegiline—Dizziness—Doxorubicin—hematologic cancer	5.5e-06	2.37e-05	CcSEcCtD
Selegiline—Nausea—Epirubicin—hematologic cancer	5.34e-06	2.3e-05	CcSEcCtD
Selegiline—Vomiting—Doxorubicin—hematologic cancer	5.29e-06	2.28e-05	CcSEcCtD
Selegiline—Rash—Doxorubicin—hematologic cancer	5.24e-06	2.26e-05	CcSEcCtD
Selegiline—Dermatitis—Doxorubicin—hematologic cancer	5.24e-06	2.26e-05	CcSEcCtD
Selegiline—Headache—Doxorubicin—hematologic cancer	5.21e-06	2.24e-05	CcSEcCtD
Selegiline—Nausea—Doxorubicin—hematologic cancer	4.94e-06	2.13e-05	CcSEcCtD
Selegiline—CYP2A6—Metabolism—MTHFR—hematologic cancer	3.96e-06	8.39e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.95e-06	8.37e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—GSTT1—hematologic cancer	3.94e-06	8.35e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—SLC22A1—hematologic cancer	3.94e-06	8.35e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—CRABP1—hematologic cancer	3.94e-06	8.35e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—GSTP1—hematologic cancer	3.93e-06	8.33e-05	CbGpPWpGaD
Selegiline—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	3.92e-06	8.3e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—HMMR—hematologic cancer	3.91e-06	8.28e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—IDH2—hematologic cancer	3.91e-06	8.28e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—GSTT1—hematologic cancer	3.91e-06	8.28e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.91e-06	8.28e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—SDC1—hematologic cancer	3.86e-06	8.17e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—GSTP1—hematologic cancer	3.85e-06	8.16e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.85e-06	8.15e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—ALOX5—hematologic cancer	3.84e-06	8.13e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—SDC1—hematologic cancer	3.82e-06	8.09e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.78e-06	8.01e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—CYCS—hematologic cancer	3.78e-06	8e-05	CbGpPWpGaD
Selegiline—MAOA—Metabolism—PIK3CD—hematologic cancer	3.77e-06	7.98e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—HSP90AA1—hematologic cancer	3.75e-06	7.95e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—ABCB1—hematologic cancer	3.72e-06	7.89e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—NUP98—hematologic cancer	3.72e-06	7.88e-05	CbGpPWpGaD
Selegiline—MAOA—Metabolism—ALB—hematologic cancer	3.72e-06	7.88e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—ARNTL—hematologic cancer	3.68e-06	7.79e-05	CbGpPWpGaD
Selegiline—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	3.67e-06	7.77e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.65e-06	7.73e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—ABCB1—hematologic cancer	3.65e-06	7.72e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—GSTM1—hematologic cancer	3.62e-06	7.66e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—NCOR1—hematologic cancer	3.62e-06	7.66e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—ADCY7—hematologic cancer	3.61e-06	7.65e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—NCOA3—hematologic cancer	3.61e-06	7.65e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.6e-06	7.63e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—NUP214—hematologic cancer	3.59e-06	7.59e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—ACP5—hematologic cancer	3.58e-06	7.58e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—CA9—hematologic cancer	3.58e-06	7.58e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—CD44—hematologic cancer	3.56e-06	7.55e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—NQO1—hematologic cancer	3.56e-06	7.55e-05	CbGpPWpGaD
Selegiline—MAOA—Metabolism—PIK3R1—hematologic cancer	3.56e-06	7.53e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	3.55e-06	7.52e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—GSTM1—hematologic cancer	3.54e-06	7.5e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—NCOR1—hematologic cancer	3.54e-06	7.5e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—NCOR2—hematologic cancer	3.53e-06	7.48e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—ABCG2—hematologic cancer	3.51e-06	7.44e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—MTR—hematologic cancer	3.51e-06	7.44e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.49e-06	7.39e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—NQO1—hematologic cancer	3.48e-06	7.37e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—CD44—hematologic cancer	3.48e-06	7.37e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.45e-06	7.3e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—ENO2—hematologic cancer	3.45e-06	7.3e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.38e-06	7.16e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—CYCS—hematologic cancer	3.37e-06	7.14e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—IDH1—hematologic cancer	3.36e-06	7.12e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	3.35e-06	7.1e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—GSTT1—hematologic cancer	3.34e-06	7.08e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—GSTP1—hematologic cancer	3.33e-06	7.05e-05	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—PIK3CG—hematologic cancer	3.33e-06	7.05e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—ABCC3—hematologic cancer	3.33e-06	7.04e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—GSTO1—hematologic cancer	3.33e-06	7.04e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—TXN—hematologic cancer	3.33e-06	7.04e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—CYCS—hematologic cancer	3.29e-06	6.97e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.29e-06	6.97e-05	CbGpPWpGaD
Selegiline—MAOA—Metabolism—PIK3CB—hematologic cancer	3.28e-06	6.95e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—CD44—hematologic cancer	3.28e-06	6.94e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—NQO1—hematologic cancer	3.28e-06	6.94e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—HSP90AA1—hematologic cancer	3.27e-06	6.93e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—SDC1—hematologic cancer	3.27e-06	6.92e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—SPHK1—hematologic cancer	3.25e-06	6.89e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—NQO1—hematologic cancer	3.25e-06	6.88e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—CD44—hematologic cancer	3.25e-06	6.88e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.22e-06	6.82e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—MTHFR—hematologic cancer	3.19e-06	6.77e-05	CbGpPWpGaD
Selegiline—MAOB—Metabolism—PIK3CA—hematologic cancer	3.19e-06	6.76e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.18e-06	6.74e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—ABCB1—hematologic cancer	3.15e-06	6.68e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—MTHFR—hematologic cancer	3.13e-06	6.63e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—UGT1A1—hematologic cancer	3.13e-06	6.62e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.12e-06	6.61e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—CYCS—hematologic cancer	3.1e-06	6.57e-05	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—CREBBP—hematologic cancer	3.08e-06	6.53e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	3.08e-06	6.53e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.08e-06	6.52e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—CYCS—hematologic cancer	3.08e-06	6.51e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—GSTM1—hematologic cancer	3.06e-06	6.48e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—NCOR1—hematologic cancer	3.06e-06	6.48e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	3.06e-06	6.47e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—SLC22A1—hematologic cancer	3.04e-06	6.44e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—CRABP1—hematologic cancer	3.04e-06	6.44e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.02e-06	6.39e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—GSTP1—hematologic cancer	2.97e-06	6.3e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—ALOX5—hematologic cancer	2.96e-06	6.28e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	2.95e-06	6.24e-05	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—PIK3CD—hematologic cancer	2.92e-06	6.19e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—GSTP1—hematologic cancer	2.9e-06	6.14e-05	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—ALB—hematologic cancer	2.89e-06	6.11e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.88e-06	6.09e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—NUP98—hematologic cancer	2.87e-06	6.08e-05	CbGpPWpGaD
Selegiline—MAOA—Metabolism—PTEN—hematologic cancer	2.84e-06	6.01e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—ABCB1—hematologic cancer	2.81e-06	5.96e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—ADCY7—hematologic cancer	2.79e-06	5.9e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—NCOA3—hematologic cancer	2.79e-06	5.9e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—NQO1—hematologic cancer	2.78e-06	5.88e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—CD44—hematologic cancer	2.78e-06	5.88e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—NUP214—hematologic cancer	2.77e-06	5.86e-05	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—PIK3R1—hematologic cancer	2.76e-06	5.85e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.75e-06	5.82e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—GSTP1—hematologic cancer	2.73e-06	5.79e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—NCOR1—hematologic cancer	2.73e-06	5.79e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—GSTM1—hematologic cancer	2.73e-06	5.79e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.72e-06	5.76e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—ABCG2—hematologic cancer	2.71e-06	5.74e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—MTR—hematologic cancer	2.71e-06	5.74e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—GSTP1—hematologic cancer	2.71e-06	5.74e-05	CbGpPWpGaD
Selegiline—MAOA—Metabolism—EP300—hematologic cancer	2.71e-06	5.73e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—MTHFR—hematologic cancer	2.7e-06	5.73e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—PIK3CG—hematologic cancer	2.68e-06	5.68e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—NCOR1—hematologic cancer	2.67e-06	5.65e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—GSTM1—hematologic cancer	2.67e-06	5.65e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—ENO2—hematologic cancer	2.66e-06	5.63e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—PIK3CG—hematologic cancer	2.63e-06	5.57e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—CYCS—hematologic cancer	2.63e-06	5.57e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.62e-06	5.55e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	2.61e-06	5.53e-05	CbGpPWpGaD
Selegiline—MAOB—Metabolism—AKT1—hematologic cancer	2.61e-06	5.52e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—ABCB1—hematologic cancer	2.59e-06	5.48e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—GSTT1—hematologic cancer	2.58e-06	5.46e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—ABCB1—hematologic cancer	2.57e-06	5.43e-05	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—PIK3CB—hematologic cancer	2.55e-06	5.4e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—SDC1—hematologic cancer	2.52e-06	5.34e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—NCOR1—hematologic cancer	2.51e-06	5.32e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—GSTM1—hematologic cancer	2.51e-06	5.32e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—GSTM1—hematologic cancer	2.49e-06	5.28e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—NCOR1—hematologic cancer	2.49e-06	5.28e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—CREBBP—hematologic cancer	2.49e-06	5.27e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—CREBBP—hematologic cancer	2.44e-06	5.16e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—MTHFR—hematologic cancer	2.41e-06	5.11e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.38e-06	5.05e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—PIK3CD—hematologic cancer	2.36e-06	5e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—MTHFR—hematologic cancer	2.36e-06	4.99e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.35e-06	4.98e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—ALB—hematologic cancer	2.33e-06	4.93e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—GSTP1—hematologic cancer	2.32e-06	4.91e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—PIK3CD—hematologic cancer	2.31e-06	4.89e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—ALB—hematologic cancer	2.28e-06	4.83e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—PIK3CG—hematologic cancer	2.27e-06	4.81e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.24e-06	4.75e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—PIK3R1—hematologic cancer	2.23e-06	4.72e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—MTHFR—hematologic cancer	2.22e-06	4.7e-05	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—PTEN—hematologic cancer	2.2e-06	4.67e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—MTHFR—hematologic cancer	2.2e-06	4.66e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—ABCB1—hematologic cancer	2.19e-06	4.64e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—PIK3R1—hematologic cancer	2.18e-06	4.62e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—CD44—hematologic cancer	2.14e-06	4.54e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—NQO1—hematologic cancer	2.14e-06	4.54e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—NCOR1—hematologic cancer	2.13e-06	4.51e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—GSTM1—hematologic cancer	2.13e-06	4.51e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.13e-06	4.51e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—CREBBP—hematologic cancer	2.11e-06	4.46e-05	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—EP300—hematologic cancer	2.1e-06	4.45e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—PIK3CB—hematologic cancer	2.06e-06	4.36e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—PIK3CG—hematologic cancer	2.03e-06	4.3e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—CYCS—hematologic cancer	2.03e-06	4.3e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.02e-06	4.27e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—PIK3CB—hematologic cancer	2.01e-06	4.27e-05	CbGpPWpGaD
Selegiline—MAOA—Metabolism—PIK3CA—hematologic cancer	2e-06	4.24e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—PIK3CD—hematologic cancer	2e-06	4.23e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—PIK3CG—hematologic cancer	1.98e-06	4.19e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—ALB—hematologic cancer	1.97e-06	4.18e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.94e-06	4.11e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—PIK3R1—hematologic cancer	1.89e-06	4e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—MTHFR—hematologic cancer	1.88e-06	3.98e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—CREBBP—hematologic cancer	1.88e-06	3.98e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—PIK3CG—hematologic cancer	1.87e-06	3.95e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—PIK3CG—hematologic cancer	1.85e-06	3.92e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—CREBBP—hematologic cancer	1.84e-06	3.89e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.79e-06	3.79e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—PIK3CD—hematologic cancer	1.78e-06	3.78e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—PTEN—hematologic cancer	1.78e-06	3.76e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—ALB—hematologic cancer	1.76e-06	3.73e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—PIK3CB—hematologic cancer	1.74e-06	3.69e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—PTEN—hematologic cancer	1.74e-06	3.69e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—PIK3CD—hematologic cancer	1.74e-06	3.69e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—CREBBP—hematologic cancer	1.73e-06	3.66e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—ALB—hematologic cancer	1.72e-06	3.64e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—CREBBP—hematologic cancer	1.71e-06	3.63e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—EP300—hematologic cancer	1.7e-06	3.59e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.69e-06	3.58e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—PIK3R1—hematologic cancer	1.68e-06	3.57e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—EP300—hematologic cancer	1.66e-06	3.52e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.66e-06	3.51e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—PIK3R1—hematologic cancer	1.64e-06	3.48e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.64e-06	3.48e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.64e-06	3.48e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—PIK3CD—hematologic cancer	1.64e-06	3.47e-05	CbGpPWpGaD
Selegiline—MAOA—Metabolism—AKT1—hematologic cancer	1.64e-06	3.46e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—PIK3CD—hematologic cancer	1.63e-06	3.44e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—ALB—hematologic cancer	1.62e-06	3.43e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—ALB—hematologic cancer	1.61e-06	3.4e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PIK3CG—hematologic cancer	1.58e-06	3.35e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—PIK3CB—hematologic cancer	1.55e-06	3.29e-05	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—PIK3CA—hematologic cancer	1.55e-06	3.29e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—PIK3R1—hematologic cancer	1.55e-06	3.28e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—PIK3R1—hematologic cancer	1.54e-06	3.25e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—PIK3CB—hematologic cancer	1.52e-06	3.21e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—PTEN—hematologic cancer	1.5e-06	3.19e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—CREBBP—hematologic cancer	1.47e-06	3.1e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.45e-06	3.07e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—EP300—hematologic cancer	1.44e-06	3.04e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—PIK3CB—hematologic cancer	1.43e-06	3.03e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—PIK3CB—hematologic cancer	1.42e-06	3e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PIK3CD—hematologic cancer	1.39e-06	2.94e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—ALB—hematologic cancer	1.37e-06	2.9e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—PTEN—hematologic cancer	1.34e-06	2.84e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PIK3R1—hematologic cancer	1.31e-06	2.78e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—PTEN—hematologic cancer	1.31e-06	2.78e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—EP300—hematologic cancer	1.28e-06	2.71e-05	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—AKT1—hematologic cancer	1.27e-06	2.69e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—PIK3CA—hematologic cancer	1.25e-06	2.66e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—EP300—hematologic cancer	1.25e-06	2.65e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—PTEN—hematologic cancer	1.24e-06	2.62e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—PIK3CA—hematologic cancer	1.23e-06	2.6e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—PTEN—hematologic cancer	1.22e-06	2.59e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.22e-06	2.58e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PIK3CB—hematologic cancer	1.21e-06	2.56e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—EP300—hematologic cancer	1.18e-06	2.49e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—EP300—hematologic cancer	1.17e-06	2.47e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.13e-06	2.4e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.07e-06	2.27e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—PIK3CA—hematologic cancer	1.06e-06	2.25e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—ALB—hematologic cancer	1.06e-06	2.24e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PTEN—hematologic cancer	1.05e-06	2.22e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—AKT1—hematologic cancer	1.02e-06	2.17e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.01e-06	2.14e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—AKT1—hematologic cancer	1e-06	2.12e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—EP300—hematologic cancer	9.98e-07	2.11e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—PIK3CA—hematologic cancer	9.48e-07	2.01e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PIK3CB—hematologic cancer	9.35e-07	1.98e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—PIK3CA—hematologic cancer	9.25e-07	1.96e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—PIK3CA—hematologic cancer	8.71e-07	1.85e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—AKT1—hematologic cancer	8.67e-07	1.84e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—PIK3CA—hematologic cancer	8.64e-07	1.83e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PTEN—hematologic cancer	8.08e-07	1.71e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—AKT1—hematologic cancer	7.74e-07	1.64e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—EP300—hematologic cancer	7.7e-07	1.63e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—AKT1—hematologic cancer	7.55e-07	1.6e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PIK3CA—hematologic cancer	7.38e-07	1.56e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—AKT1—hematologic cancer	7.12e-07	1.51e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—AKT1—hematologic cancer	7.06e-07	1.49e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—AKT1—hematologic cancer	6.03e-07	1.28e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PIK3CA—hematologic cancer	5.7e-07	1.21e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—AKT1—hematologic cancer	4.65e-07	9.86e-06	CbGpPWpGaD
